Celltrion Inc Sustainability Reports
Celltrion Inc. is a South Korean biopharmaceutical company specializing in the research, development, and manufacture of biosimilars and novel biological therapeutics. The company produces monoclonal antibodies for the treatment of autoimmune diseases, oncology, and other severe therapeutic indications.
Sector: Manufacturing
Country: South Korea
Exchange: Korea Exchange (KOSPI)
LEI: 988400JFZG785WJX3D68
FIGI: BBG001SNFZR3
3 reports from 2021 to 2022
